Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

Completed · Phase 4 · Has a placebo group

Conditions studied: Pneumonia, Acute Respiratory Disease

In brief

The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and * comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.

Key facts

Study ID

NCT02079701

Run by

Naval Health Research Center

People needed

152723

Starts

2000-10-01

Expected to finish

2007-06-01

Last updated by the study team

2014-03-06

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• basic training recruits at 5 recruit training centers (in South Carolina, Missouri, Illinois, and California) were invited to participate during their first week of training from Oct 2000 through Jun 2003

You may not qualify if…

• positive pregnancy results
• having previously received the a 23-valent pneumococcal vaccine during the previous 5 years or
• having a medical condition that either required or precluded pneumococcal vaccination

Where it is running

• Marine Recruit Training Center — San Diego, California, United States
• Naval Recruit Training Center — Great Lakes, Illinois, United States
• Army Recruit Training Center — Fort Leonard Wood, Missouri, United States
• Army Recruit Training Center — Fort Jackson, South Carolina, United States
• Marine Recruit Training Center — Parris Island, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.